BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 15857710)

  • 1. Monoaminergic dysregulation in glutathione-deficient mice: possible relevance to schizophrenia?
    Jacobsen JP; Rodriguiz RM; Mørk A; Wetsel WC
    Neuroscience; 2005; 132(4):1055-72. PubMed ID: 15857710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine release in the nucleus accumbens (shell) of two lines of rats selectively bred to prefer or avoid ethanol.
    Quintanilla ME; Bustamante D; Tampier L; Israel Y; Herrera-Marschitz M
    Eur J Pharmacol; 2007 Nov; 573(1-3):84-92. PubMed ID: 17651729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of subchronic exposure to styrene on the extracellular and tissue levels of dopamine, serotonin and their metabolites in rat brain.
    Gagnaire F; Chalansonnet M; Carabin N; Micillino JC
    Arch Toxicol; 2006 Oct; 80(10):703-12. PubMed ID: 16518643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of interactions between phencyclidine and amphetamine in rodent prefrontal cortex and striatum: implications in NMDA/glycine-site-mediated dopaminergic dysregulation and dopamine transporter function.
    Sershen H; Balla A; Aspromonte JM; Xie S; Cooper TB; Javitt DC
    Neurochem Int; 2008 Jan; 52(1-2):119-29. PubMed ID: 17716783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Netrin-1 receptor-deficient mice show enhanced mesocortical dopamine transmission and blunted behavioural responses to amphetamine.
    Grant A; Hoops D; Labelle-Dumais C; Prévost M; Rajabi H; Kolb B; Stewart J; Arvanitogiannis A; Flores C
    Eur J Neurosci; 2007 Dec; 26(11):3215-28. PubMed ID: 18005074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental study of methamphetamine psychosis--role of glutamate and nitric oxide in methamphetamine-induced dopaminergic and serotonergic neurotoxicity in the rat brain].
    Abekawa T
    Hokkaido Igaku Zasshi; 1997 Jan; 72(1):113-26. PubMed ID: 9086367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methamphetamine-elicited alterations of dopamine- and serotonin-metabolite levels within mu-opioid receptor knockout mice: a microdialysis study.
    Lan KC; Ma T; Lin-Shiau SY; Liu SH; Ho IK
    J Biomed Sci; 2008 May; 15(3):391-403. PubMed ID: 17934798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific abnormalities in serotonin release in the prefrontal cortex of isolation-reared rats measured during behavioural performance of a task assessing visuospatial attention and impulsivity.
    Dalley JW; Theobald DE; Pereira EA; Li PM; Robbins TW
    Psychopharmacology (Berl); 2002 Nov; 164(3):329-40. PubMed ID: 12424557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine.
    Nabeshima T; Mouri A; Murai R; Noda Y
    Ann N Y Acad Sci; 2006 Nov; 1086():160-8. PubMed ID: 17185514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased glutathione levels and altered antioxidant defense in an animal model of schizophrenia: long-term effects of perinatal phencyclidine administration.
    Radonjić NV; Knezević ID; Vilimanovich U; Kravić-Stevović T; Marina LV; Nikolić T; Todorović V; Bumbasirević V; Petronijević ND
    Neuropharmacology; 2010; 58(4-5):739-45. PubMed ID: 20036264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of a dysfunctional dopamine-D1/N-methyl-d-aspartate-NR1 and Ca2+/calmodulin-dependent protein kinase II pathway in the impairment of latent learning in a model of schizophrenia induced by phencyclidine.
    Mouri A; Noda Y; Noda A; Nakamura T; Tokura T; Yura Y; Nitta A; Furukawa H; Nabeshima T
    Mol Pharmacol; 2007 Jun; 71(6):1598-609. PubMed ID: 17344353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of deramciclane, ritanserin and buspirone on extracellular dopamine and its metabolites in striatum and nucleus accumbens of freely moving rats.
    Kääriäinen TM; Lehtonen M; Forsberg MM; Savolainen J; Käenmäki M; Männistö PT
    Basic Clin Pharmacol Toxicol; 2008 Jan; 102(1):50-8. PubMed ID: 17971064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: relevance to schizophrenia.
    Steullet P; Neijt HC; Cuénod M; Do KQ
    Neuroscience; 2006 Feb; 137(3):807-19. PubMed ID: 16330153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered N-methyl-D-aspartate receptor function in reelin heterozygous mice: male-female differences and comparison with dopaminergic activity.
    van den Buuse M; Halley P; Hill R; Labots M; Martin S
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Jun; 37(2):237-46. PubMed ID: 22361156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dorsal and ventral hippocampal NMDA stimulation on nucleus accumbens core and shell dopamine release.
    Peleg-Raibstein D; Feldon J
    Neuropharmacology; 2006 Oct; 51(5):947-57. PubMed ID: 16876207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMDA antagonist effects on striatal dopamine release: microdialysis studies in awake monkeys.
    Adams BW; Bradberry CW; Moghaddam B
    Synapse; 2002 Jan; 43(1):12-8. PubMed ID: 11746729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subchronic continuous phencyclidine administration potentiates amphetamine-induced frontal cortex dopamine release.
    Balla A; Sershen H; Serra M; Koneru R; Javitt DC
    Neuropsychopharmacology; 2003 Jan; 28(1):34-44. PubMed ID: 12496938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.
    Javitt DC
    Int Rev Neurobiol; 2007; 78():69-108. PubMed ID: 17349858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Netrin receptor deficient mice exhibit functional reorganization of dopaminergic systems and do not sensitize to amphetamine.
    Flores C; Manitt C; Rodaros D; Thompson KM; Rajabi H; Luk KC; Tritsch NX; Sadikot AF; Stewart J; Kennedy TE
    Mol Psychiatry; 2005 Jun; 10(6):606-12. PubMed ID: 15534618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral and neurochemical characterization of mice deficient in the phosphodiesterase-1B (PDE1B) enzyme.
    Siuciak JA; McCarthy SA; Chapin DS; Reed TM; Vorhees CV; Repaske DR
    Neuropharmacology; 2007 Jul; 53(1):113-24. PubMed ID: 17559891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.